Willow Biosciences Inc (FRA:3D7)
€ 0.0725 0 (0%) Market Cap: 10.37 Mil Enterprise Value: 10.64 Mil PE Ratio: 0 PB Ratio: 10.00 GF Score: 33/100

Willow Biosciences Inc at SRAX Sequire Biotechnology Conference (Virtual) Transcript

Feb 02, 2023 / 06:00PM GMT
Release Date Price: €0.065
Peter Seufer;Wasserthal
Willow Biosciences Inc. - President and CEO

Good morning. I'd like to start by thanking everyone joining us on today's presentation. I'm Peter Seufer-Wasserthal, President and CEO of Willow Biosciences. I've been with the company on the Board since its inception and was asked to step in as interim CEO back in July last year and then was appointed permanent CEO in November of 2022.

It was an exciting time because it allowed me to see what Willow has built, and I want to share some of this excitement in the next few minutes with you. Before we go into that, there is a long or a brief disclaimer. You can read through that on our website. Please go ahead if you want to do that.

And now with that, let me continue with a summary of our business, our core capabilities, our capital structure, key strength, and how we do things. We were founded in 2019 as a company in Canada based on making cannabis products in yeast using precision fermentation. I will come back to that in a second. But now, the majority of our research team is in Mountain View,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot